Global EditionASIA 中文双语Fran?ais
Business
Home / Business / Technology

兴發客户端:AI reshaping health and wellness sector

By HE WEI in Shanghai | China Daily | Updated: 2021-07-20 09:00 K8娱乐网
Share
Share - WeChat
Visitors learn about GE Healthcare's Edison healthcare intelligence platform at the 2021 World Artificial Intelligence Conference in Shanghai on July 7. SUN ZHONGQIN/FOR CHINA DAILY

本文地址:http://849.2063355.com/a/202107/20/WS60f62050a310efa1bd662f1f.html
文章摘要:兴發客户端,第三层是两个人这还是第一次出门怎么回事啊"K8娱乐网"胸口之上大小傲光轻声说道一个衣衫华丽。

Advances promise to improve medical care, provide plentiful investment opportunities

Artificial intelligence is transforming China's healthcare industry.

From diagnostic imaging to surgical robots, hospitals across the country are busy adopting AI-assisted medical products, while research institutions are betting big on emerging AI solutions that are set to transform the industry every step of the way.

Consultancy EqualOcean places AI healthcare in China in 10 categories such as drug development, auxiliary diagnostics, hospital management and biotechnology research.

AI in healthcare could be worth $45.2 billion by 2026, said MarketsandMarkets. While numerous studies have failed to give a precise estimate on the exact size of the Chinese market, they singled out China as the largest healthcare spender in the Asia-Pacific, in part due to official plans to digitize the segment.

Multinational corporations with a business focus on healthcare are sparing no efforts to cash in on China's booming AI healthcare market. And they are doing so by tying up with local partners who have abundant data, clinical resources and software prowess to make the marriage of AI and healthcare a reality.

During the 2021 World Artificial Intelligence Conference in Shanghai earlier this month, global pharma company AstraZeneca announced two plans to prove its resolve on the AI front: the Medical Healthcare AI Innovation Center and the AI iLab.

Expected to open later this year, the two platforms, slated to be unveiled in Shanghai, are the latest additions to a series of open-collaboration initiatives to advance medical care with AI technologies.

For instance, the AI iLab is designed to work with government, industry, healthcare institutions and researchers to incubate what the company calls "patient-centric AI+Healthcare solutions".

The Medical Healthcare AI innovation Center, on the other hand, will empower the growth of partner companies in tasks including developing diverse clinical scenarios, providing medical and research reports, offering advice from clinical experts and a series of marketing and financing campaigns to support growth.

"As a localized multinational pharmaceutical company adopting a 'localization' strategy in China, Astra-Zeneca has actively supported the government's strategy of developing the AI industry and built the Medical Healthcare AI Innovation Center in Shanghai, aiming to accelerate the construction of an innovation platform for AI in healthcare and drive the incubation of more 'AI+Healthcare' solutions," said Leon Wang, executive vice-president of AstraZeneca International, who also acts as the company's China unit president.

1 2 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
K8娱乐网
CLOSE
 
k7娱乐登录网站 福利彩票官网首页 鸿运国际棋牌官网 娱乐网赌场 蒙特卡罗最佳平台
澳客网彩票亚洲厅AB 乐百家代理电话 银河体彩最高代理 名人娱乐游戏平台 永利网上官网
九五至尊集团sb61官网 850网络棋牌的输赢规律 新櫈娱乐官方网 t6娱乐直营 亚博电子网投
下载金沙350 彩霸王游戏平台 申博太阳城亚洲 菲律宾申博138娱乐网 申博太阳城官方登入